This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National Cancer Center, Protanbio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 264 
1 out of 1 Years Active: 2026
Title: Soyoun Ro: Innovator in Cancer Therapy
Introduction
Soyoun Ro is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of cancer therapy, particularly through his innovative research and development of chimeric antigen receptors.
Latest Patents
Soyoun Ro holds a patent for a groundbreaking invention titled "Chimeric Antigen Receptor Targeting BCMA and Use Thereof." This patent represents a significant advancement in targeted cancer therapies, specifically for conditions related to BCMA.
Career Highlights
Throughout his career, Soyoun Ro has worked with esteemed organizations such as the National Cancer Center and Protanbio Inc. His work in these institutions has been pivotal in advancing cancer treatment methodologies.
Collaborations
Soyoun Ro has collaborated with notable colleagues, including Sangjin Lee and Hyeonseok Eom. These partnerships have fostered a collaborative environment that enhances innovation in cancer research.
Conclusion
Soyoun Ro's contributions to cancer therapy through his patent and collaborative efforts highlight his role as a key innovator in the field. His work continues to inspire advancements in medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile